Abstract:Background and objectives: Inherited thrombocytopenias are a heterogeneous group of rare diseases characterized by a reduced number of blood platelets. Some of these diseases are exclusive to megakaryocytes and platelets, while in others the pathology extends to other cell types. Although the defective genes, coding for membrane glyoproteins, cytoskeleton components and intracellular signaling pathways, as well as transcription factors, have been identified in most cases, the pathophysiology of these disorders is often unknown. This review describes recent contributions to clinical and diagnostic aspects, biology and treatments of familial thrombocytopenias. Evidence and information sources: The information presented here derives from literature and the experience of the authors. The most relevant studies are critically analyzed and discussed. State of art: The clinical and laboratory features of most of the inherited thrombocytopenias have been reviewed. The different forms have been classified into 3 groups depending on platelet volume. Although this criterion is not completely satisfactory, it is one of the most useful in diagnostic algorithms. We report on recent advances in Wiskott-Aldrich and Bernard-Soulier syndromes, as well as in MYH9-related diseases, a new nosological entity that groups old distinct forms known as May-Hegglin anomaly, Sebastian, Fetchner, and Epstein syndromes. Other, less frequent forms are also discussed, including non-syndromic forms of mild thrombocytopenia that are genetically heterogeneous. Perspectives: In the past, inherited thrombocytopenias were considered exceedingly rare and the number of well-defined forms was very small. In the last few years, the widespread diffusion of electronic cell counters has allowed these conditions to be detected more frequently and several new entities have been identified through the co-ordinated efforts of physicians, biologists and geneticists. The pathogenesis of many new and old forms is being unraveled, thus providing insights on the molecular basis of platelet production and function. This knowledge will be a valuable resource for clinicians in the diagnostic approaches to such disorders.

Thrombotic events in MYH9 gene-related autosomal macrothrombocytopenias (old May-Hegglin, Sebastian, Fechtner and Epstein syndromes)

Genotype-phenotype correlation in MYH9-related thrombocytopenia

A De Novo Mutation in MYH9 in a Child With Severe and Prolonged Macrothrombocytopenia

Myosin Heavy Chain 9 (MYH9)-Related Congenital Macrothrombocytopenia

[Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders]

[Case of an hemodialysis patient with MYH9 disorders]

Linking the Landscape of MYH9-Related Diseases to the Molecular Mechanisms that Control Non-Muscle Myosin II-A Function in Cells

[Hereditary thrombocytopenia associated with a mutation in the MYH-9 gene. Report of one case]

Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9-related disease

Perioperative management of MYH9 hereditary macrothrombocytopenia (Fechtner syndrome)

MYH9-related disorders: report on a patient of Greek origin presenting with macroscopic hematuria and presenile cataract, caused by an R1165C mutation

Hereditary thrombocytopenia with familial novel mutation in MYH9 gene: A familial case report

R1933X mutation in the MYH9 gene in May-Hegglin anomaly mimicking idiopathic thrombocytopenic purpura

MYH9-related inherited thrombocytopenia: the genetic spectrum, underlying mechanisms, clinical phenotypes, diagnosis, and management approaches

[Clinical Features and Gene Analyses of Six Patients with MYH9-related Disease].

[Hereditary sensorineural hearing impairment and macrothrombocytopenia: a rare MYH9 gene mutation]

Inherited thrombocytopenias: from genes to therapy

MYH9 spectrum of autosomal-dominant giant platelet syndromes: unexpected association with fibulin-1 variant-D inactivation

Hereditary thrombocytopenia with platelet sialic acid deficiency and mutations in the GNE genes

Case Report: MYH9-related disease caused by Ala44Pro mutation in a child with a previous diagnosis of chronic immune thrombocytopenia

Hereditary thrombocytopenias: a growing list of disorders